ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$131.41M
↑ 184% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-155.75M
Historical baseline
PeriodValueYoY Change
TTM$131.41M+31.2%
2024$100.16M+247.7%
2023$-67.83M+69.4%
2022$-221.57M-32.6%
2021$-167.09M+41.1%
2020$-283.65M-16.4%
2019$-243.78M+0.3%
2018$-244.44M+15.6%
2017$-289.70M-6.9%
2016$-270.99M-